| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1590 | 2018 |
| HIV, viral hepatitis and sexually transmissible infections in Australia S McGregor, H McManus, R Gray The Kirby Institute, 2016 | 444 | 2016 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 406 | 2022 |
| Optima: a model for HIV epidemic analysis, program prioritization, and resource optimization CC Kerr, RM Stuart, RT Gray, AJ Shattock, N Fraser-Hurt, C Benedikt, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 69 (3), 365-376, 2015 | 120 | 2015 |
| Frequent testing of highly sexually active gay men is required to control syphilis RT Gray, A Hoare, GP Prestage, B Donovan, JM Kaldor, DP Wilson Sexually transmitted diseases 37 (5), 298-305, 2010 | 120 | 2010 |
| Mean-field modeling of the basal ganglia-thalamocortical system. II: dynamics of parkinsonian oscillations SJ van Albada, RT Gray, PM Drysdale, PA Robinson Journal of theoretical biology 257 (4), 664-688, 2009 | 119 | 2009 |
| Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study D Razavi-Shearer, I Gamkrelidze, C Pan, J Jia, T Berg, R Gray, YS Lim, ... The Lancet Gastroenterology & Hepatology 8 (10), 879-907, 2023 | 116 | 2023 |
| The potential impact of vaccination on the prevalence of gonorrhea AP Craig, RT Gray, JL Edwards, MA Apicella, MP Jennings, DP Wilson, ... Vaccine 33 (36), 4520-4525, 2015 | 104 | 2015 |
| Modeling the Impact of Potential Vaccines on Epidemics of Sexually Transmitted Chlamydia trachomatis Infection RT Gray, KW Beagley, P Timms, DP Wilson The Journal of infectious diseases 199 (11), 1680-1688, 2009 | 96 | 2009 |
| Increased HIV testing will modestly reduce HIV incidence among gay men in NSW and would be acceptable if HIV testing becomes convenient RT Gray, GP Prestage, I Down, MH Ghaus, A Hoare, J Bradley, DP Wilson PloS one 8 (2), e55449, 2013 | 88 | 2013 |
| Chronic hepatitis C burden and care cascade in Australia in the era of interferon‐based treatment B Hajarizadeh, J Grebely, H McManus, C Estes, H Razavi, RT Gray, ... Journal of gastroenterology and hepatology 32 (1), 229-236, 2017 | 87 | 2017 |
| A cost-effectiveness analysis of HIV preexposure prophylaxis for men who have sex with men in Australia K Schneider, RT Gray, DP Wilson Clinical infectious diseases 58 (7), 1027-1034, 2014 | 81 | 2014 |
| Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: a modelling study JA Kwon, GJ Dore, J Grebely, B Hajarizadeh, R Guy, EB Cunningham, ... Journal of viral hepatitis 26 (1), 83-92, 2019 | 77 | 2019 |
| Dynamical reconnection and stability constraints on cortical network architecture PA Robinson, JA Henderson, E Matar, P Riley, RT Gray Physical review letters 103 (10), 108104, 2009 | 72 | 2009 |
| HIV, viral hepatitis and sexually transmissible infections in Australia Annual surveillance report 2021 J King, H McManus, R Gray, S McGregor The Kirby Insitute, UNSW Sydney, 2022 | 67 | 2022 |
| Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models D Keebler, P Revill, S Braithwaite, A Phillips, N Blaser, A Borquez, ... The Lancet Global Health 2 (1), e35-e43, 2014 | 65 | 2014 |
| Chemoprophylaxis is likely to be acceptable and could mitigate syphilis epidemics among populations of gay men DP Wilson, GP Prestage, RT Gray, A Hoare, P McCann, I Down, RJ Guy, ... Sexually transmitted diseases 38 (7), 573-579, 2011 | 57 | 2011 |
| The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS SL Kelly, R Martin-Hughes, RM Stuart, XF Yap, DJ Kedziora, ... The lancet HIV 5 (4), e190-e198, 2018 | 52 | 2018 |
| Estimating the number of people who inject drugs in Australia S Larney, M Hickman, R Guy, J Grebely, GJ Dore, RT Gray, CA Day, ... BMC public health 17, 1-7, 2017 | 52 | 2017 |
| Understanding COVID-19 dynamics and the effects of interventions in the Philippines: A mathematical modelling study JM Caldwell, E de Lara-Tuprio, TR Teng, MRJE Estuar, RFR Sarmiento, ... The Lancet Regional Health–Western Pacific 14, 2021 | 39 | 2021 |
David WilsonUniversity of New South Wales, Burnet Institute, Bill and Melinda Gates Foundation, QueenslandVerified email at burnet.edu.au
